Dr Margaret Kearns, Richard Laurenson Smith
Excimer laser treatment may be via surface treatment (PRK) or LASIK. Often a choice needs to be made between the two treatment possibilities and time of recovery looms large. Recovery after treatment varies and it is important to advise patients as accu-rately as possible before treatment how they will feel, when they can return to work, how long they will need to use drops and when full visual recovery can be expected. Our purpose is to answer these questions.
We studied prospectively TransPRK patients treated at Sydney Eye Specialist Centre between June 2011 and October 2001. All patients were treated with Schwind Amaris Excimer Laser 750.
All patients were assessed at 5days and 2weeks post treatment for visual acuity and comfort.All patients were assessed at 4weeks and 8weeks post treatment for visual acuity, haze and use of drops.Patient satisfaction survey was given to patients to complete at 2 week visit.
We will provide a more factual picture of recovery from TransPRK to surgeons and patients prior to treatment. We hope to document satisfaction felt with this recent modification of PRK.
COMPARISON OF RANIBIZUMAB AND AFLIBERCEPT IN PATIENTS WITH NEOVASCULAR AGE-RELATED MACULAR DEGENERATION TREATED FOLLOWING A ?TREAT AND EXTEND? PROTOCOL: EFFICACY VARIABLES FROM THE PRE-SPECIFIED 12- MONTH INTERIM ANALYSIS OF THE RIVAL STUDY